What is DMAAR's relative strength rating?

Relative strength percentiles for DMAAR are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is DMAAR in?

DMAAR is classified under the Financials sector within the Trading industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Financials is currently ranked 4 of 11 sectors by relative strength.

Is DMAAR in a leading sector?

Yes — Financials ranks at the 73th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). DMAAR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is DMAAR?

Volatility metrics for DMAAR — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.

Does DMAAR have a seasonal pattern?

TickerStance computes DMAAR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what DMAAR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did DMAAR last report earnings?

No SEC EDGAR filings are linked to DMAAR in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Drugs Made In America Acquisition Corp. Rights (DMAAR)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Drugs Made In America Acquisition Corp. Rights (DMAAR) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile —

!ADR%—!A/D—!RVOL—!$ Vol—

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2025

Best monthJul on averageavg +51.35% · 100% win · n 2

Worst monthJan on averageavg -25.95% · 0% win · n 1

DMAAR monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	DMAAR Jan avg: -25.95% median: -25.95% win: 0% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAAR Feb avg: -17.89% median: -17.89% win: 0% σ: 24.36% n: 2 2025-02-26 → 2026-07-31	DMAAR Mar avg: -23.11% median: -23.11% win: 0% σ: 13.83% n: 2 2025-02-26 → 2026-07-31	DMAAR Apr avg: 16.44% median: 16.44% win: 50% σ: 44.89% n: 2 2025-02-26 → 2026-07-31	DMAAR May avg: 30.24% median: 30.24% win: 100% σ: 8.48% n: 2 2025-02-26 → 2026-07-31	DMAAR Jun avg: -10.47% median: -10.47% win: 0% σ: 13.29% n: 2 2025-02-26 → 2026-07-31	DMAAR Jul avg: 51.35% median: 51.35% win: 100% σ: 8.33% n: 2 2025-02-26 → 2026-07-31	DMAAR Aug avg: -4.76% median: -4.76% win: 0% σ: 0.00% n: 1 2025-02-26 → 2026-07-31 (current)	DMAAR Sep avg: 20.78% median: 20.78% win: 100% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAAR Oct avg: -19.73% median: -19.73% win: 0% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAAR Nov avg: 8.88% median: 8.88% win: 100% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAAR Dec avg: -1.42% median: -1.42% win: 0% σ: 0.00% n: 1 2025-02-26 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

—

3m

—

6m

—

1y

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · DMAAR

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Financials · 73th pctile in sector

Top peers · Financials

Who else is leading?

TOP
99RS 3m
APPS
99RS 3m
LIFE
98RS 3m

Sector vs market

Financials · 4 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials

Public attention · DMAAR

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

Reference

Company snapshot

SectorFinancials

IndustryTrading

SIC6770

Floatn/a

Shares outn/a

Market capn/a

FAQ

Frequently asked questions

What is DMAAR's relative strength rating?: Relative strength percentiles for DMAAR are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is DMAAR in?: DMAAR is classified under the Financials sector within the Trading industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Financials is currently ranked 4 of 11 sectors by relative strength.
Is DMAAR in a leading sector?: Yes — Financials ranks at the 73th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). DMAAR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is DMAAR?: Volatility metrics for DMAAR — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.
Does DMAAR have a seasonal pattern?: TickerStance computes DMAAR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what DMAAR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Drugs Made In America Acquisition Corp. Rights (DMAAR) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Financials · 4 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Drugs Made In America Acquisition Corp. Rights (DMAAR) — Stance & relative strength

DMAAR is not confirmed as a leader. 3m RS is unavailable, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Financials · 4 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?